A patient-aware benchmarking of CNN and transformer architectures for breast cancer histopathology classification
-
By
-
Veeram Priyanka
-
Modigari Narendra
-
Tharasi Dilleswar Rao
-
May 8, 2026
-
Clinical Scorecard: Patient-Centric Evaluation of CNN and Transformer Models for Classifying Breast Cancer Histopathology Images
At a Glance
| Category | Detail |
| Condition | Breast Cancer Histopathology Classification |
| Key Mechanisms | Deep learning models including CNNs and transformers for image analysis. |
| Target Population | Patients with breast cancer requiring histopathological diagnosis. |
| Care Setting | Clinical pathology laboratories. |
Key Highlights
- Nine deep learning architectures evaluated on the BreaKHis dataset.
- Strict 5-fold patient-aware cross-validation protocol used.
- ResNet50 achieved the highest mean accuracy (0.9267 ± 0.0435).
- No statistically significant differences in performance among models.
- Intermediate magnification levels provided better feature discrimination.
Guideline-Based Recommendations
Diagnosis
- Utilize automated deep learning models to assist in histopathological diagnosis.
Management
- Implement patient-aware evaluation protocols to avoid data leakage.
Monitoring & Follow-up
- Regularly assess model performance using standardized metrics.
Risks
- Be cautious of over-optimistic performance estimates due to data leakage.
Patient & Prescribing Data
Patients diagnosed with breast cancer requiring histopathological evaluation.
Automated systems can enhance diagnostic efficiency and consistency.
Clinical Best Practices
- Adopt rigorous benchmarking frameworks for model evaluation.
- Ensure uniform training conditions across different model architectures.
- Focus on reproducibility in model performance assessments.
References